Holen Sie sich die Stockscreener-App
7.83
2.89%
0.22
Handel nachbörslich:
7.78
-0.05
-0.64%
Schlusskurs vom Vortag:
$7.61
Offen:
$7.65
24-Stunden-Volumen:
1.89M
Relative Volume:
1.02
Marktkapitalisierung:
$574.86M
Einnahmen:
$161.10M
Nettoeinkommen (Verlust:
$-308.60M
KGV:
-1.6767
EPS:
-4.67
Netto-Cashflow:
$-259.90M
1W Leistung:
+1.29%
1M Leistung:
+2.89%
6M Leistung:
-55.24%
1J Leistung:
-68.62%
1-Tages-Spanne:
$7.63
$8.20
1-Wochen-Bereich:
$7.47
$8.20
52-Wochen-Spanne:
$5.90
$29.61
Arvinas Inc Stock (ARVN) Company Profile
Firmenname
Arvinas Inc
Sektor
Branche
Telefon
203-535-1456
Adresse
395 WINCHESTER AVE, NEW HAVEN, CT
Vergleichen Sie ARVN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARVN
Arvinas Inc
|
7.83 | 558.71M | 161.10M | -308.60M | -259.90M | -4.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Arvinas Inc Stock (ARVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-05-05 | Herabstufung | Truist | Buy → Hold |
| 2025-05-02 | Herabstufung | Jefferies | Buy → Hold |
| 2025-05-02 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-03-13 | Herabstufung | Goldman | Buy → Neutral |
| 2025-03-12 | Herabstufung | Wedbush | Outperform → Neutral |
| 2025-03-11 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-12-10 | Eingeleitet | BTIG Research | Buy |
| 2024-11-18 | Eingeleitet | Stephens | Overweight |
| 2024-02-28 | Bestätigt | Oppenheimer | Outperform |
| 2024-02-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-02-01 | Eingeleitet | Goldman | Buy |
| 2023-12-19 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-12-06 | Hochstufung | Jefferies | Hold → Buy |
| 2023-11-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2023-10-23 | Hochstufung | Wedbush | Neutral → Outperform |
| 2023-06-26 | Fortgesetzt | Oppenheimer | Outperform |
| 2023-01-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-01-03 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-09-09 | Eingeleitet | Barclays | Overweight |
| 2022-06-21 | Eingeleitet | Jefferies | Hold |
| 2022-05-09 | Herabstufung | Wedbush | Outperform → Neutral |
| 2022-04-28 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-06 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-02-11 | Fortgesetzt | BMO Capital Markets | Outperform |
| 2022-02-10 | Eingeleitet | Wells Fargo | Overweight |
| 2022-01-19 | Eingeleitet | Goldman | Buy |
| 2021-12-07 | Eingeleitet | Cowen | Outperform |
| 2021-10-14 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-30 | Eingeleitet | Stifel | Buy |
| 2021-09-09 | Eingeleitet | BofA Securities | Buy |
| 2021-05-21 | Eingeleitet | UBS | Buy |
| 2021-04-21 | Eingeleitet | Truist | Buy |
| 2021-03-31 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-12-14 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-06-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-05-12 | Eingeleitet | Oppenheimer | Perform |
| 2019-12-19 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-11-25 | Eingeleitet | Guggenheim | Buy |
| 2019-10-24 | Hochstufung | Goldman | Neutral → Buy |
| 2019-09-25 | Eingeleitet | Wedbush | Outperform |
| 2019-09-12 | Eingeleitet | BMO Capital Markets | Outperform |
| 2019-08-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-05 | Herabstufung | Citigroup | Buy → Neutral |
| 2019-04-12 | Eingeleitet | Evercore ISI | Outperform |
| 2018-10-22 | Eingeleitet | Citigroup | Buy |
| 2018-10-22 | Eingeleitet | Goldman | Neutral |
| 2018-10-22 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Arvinas Inc Aktie (ARVN) Neueste Nachrichten
Nuveen LLC Buys Shares of 166,597 Arvinas, Inc. $ARVN - MarketBeat
Graham Capital Management L.P. Grows Stake in Arvinas, Inc. $ARVN - MarketBeat
Russell Investments Group Ltd. Raises Stock Holdings in Arvinas, Inc. $ARVN - MarketBeat
What’s next for Arvinas Inc. stock priceJuly 2025 Sector Moves & Reliable Breakout Forecasts - Newser
Will Arvinas Inc. face regulatory challengesIndex Update & Weekly Setup with ROI Potential - خودرو بانک
Predicting Arvinas Inc. trend using moving averages2025 Trading Volume Trends & Real-Time Volume Spike Alerts - Newser
Is Arvinas Inc. stock a good dividend stockJuly 2025 Market Mood & High Accuracy Trade Alerts - خودرو بانک
How to use a screener to detect Arvinas Inc. breakoutsLayoff News & Free Weekly Chart Analysis and Trade Guides - Newser
Trend analysis for Arvinas Inc. this weekPortfolio Update Summary & Weekly Breakout Opportunity Watchlist - Newser
Analyzing Arvinas Inc. with multi timeframe chartsInflation Watch & Risk Controlled Stock Pick Alerts - Newser
Using data filters to optimize entry into Arvinas Inc.Quarterly Profit Report & AI Forecasted Entry and Exit Points - Newser
Arvinas, Inc. (NASDAQ:ARVN) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
What’s the RSI of Arvinas Inc. stockPortfolio Gains Report & Consistent Profit Alerts - خودرو بانک
Is Arvinas Inc. building a consolidation baseShare Buyback & Free Daily Entry Point Trade Alerts - Newser
Arvinas, Inc. $ARVN Holdings Trimmed by Charles Schwab Investment Management Inc. - MarketBeat
ADAR1 Capital Management LLC Invests $2.20 Million in Arvinas, Inc. $ARVN - MarketBeat
Key metrics from Arvinas Inc.’s quarterly data2025 Top Decliners & Safe Swing Trade Setups - Newser
Arvinas, Inc. (NASDAQ:ARVN) Stake Jumps 194% at XTX Topco - MSN
Statistical indicators supporting Arvinas Inc.’s strength2025 Winners & Losers & Real-Time Buy Signal Alerts - Newser
Does Arvinas Inc. offer margin of safetyQuarterly Earnings Summary & Fast Entry Momentum Trade Alerts - خودرو بانک
Arvinas to Participate in Upcoming Investor Conferences - 富途牛牛
What indicators show strength in Arvinas Inc.2025 Momentum Check & Consistent Profit Trading Strategies - Newser
How sentiment analysis helps forecast Arvinas Inc.Quarterly Earnings Summary & Weekly Watchlist for Hot Stocks - Newser
How to use Fibonacci retracement on Arvinas Inc.Earnings Growth Summary & Stock Portfolio Risk Control - Newser
What to expect from Arvinas Inc. in the next 30 daysStock Surge & Low Risk High Reward Trade Ideas - Newser
What Fibonacci levels say about Arvinas Inc. reboundIPO Watch & Trade Opportunity Analysis - Newser
Published on: 2025-09-02 23:09:55 - Newser
Does Arvinas Inc. meet Warren Buffett’s criteriaJuly 2025 News Drivers & Reliable Momentum Entry Alerts - خودرو بانک
What institutional flow reveals about Arvinas Inc.Gold Moves & Smart Swing Trading Techniques - Newser
Is Arvinas Inc. a speculative investmentJuly 2025 Levels & Weekly Breakout Opportunity Watchlist - خودرو بانک
Can Arvinas Inc. deliver alphaJuly 2025 Gainers & Verified Chart Pattern Signals - خودرو بانک
What makes Arvinas Inc. stock attractive today2025 Market Sentiment & Real-Time Volume Analysis - خودرو بانک
How to integrate Arvinas Inc. into portfolio analysis toolsMarket Risk Report & Fast Gain Stock Trading Tips - Newser
Is Arvinas Inc. stock showing strong momentumMarket Growth Review & Technical Entry and Exit Tips - خودرو بانک
Will Arvinas Inc. stock recover after earningsAnalyst Upgrade & Weekly Breakout Stock Alerts - خودرو بانک
Analyzing Arvinas Inc. with risk reward ratio chartsGap Up & Free High Accuracy Swing Entry Alerts - Newser
Arvinas Inc. Building a Base Near Support getLinesFromResByArray error: size == 0 - 강소기업뉴스
Applying big data sentiment scoring on Arvinas Inc.2025 Top Gainers & Smart Investment Allocation Tips - Newser
Finanzdaten der Arvinas Inc-Aktie (ARVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):